rs782165735

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4BP6BS2

The NM_000291.4(PGK1):​c.1234G>A​(p.Asp412Asn) variant causes a missense change. The variant allele was found at a frequency of 0.000094 in 1,201,765 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 37 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. D412D) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000063 ( 0 hom., 1 hem., cov: 23)
Exomes 𝑓: 0.000097 ( 0 hom. 36 hem. )

Consequence

PGK1
NM_000291.4 missense

Scores

1
6
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 7.18

Publications

3 publications found
Variant links:
Genes affected
PGK1 (HGNC:8896): (phosphoglycerate kinase 1) The protein encoded by this gene is a glycolytic enzyme that catalyzes the conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate. The encoded protein may also act as a cofactor for polymerase alpha. Additionally, this protein is secreted by tumor cells where it participates in angiogenesis by functioning to reduce disulfide bonds in the serine protease, plasmin, which consequently leads to the release of the tumor blood vessel inhibitor angiostatin. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Deficiency of the enzyme is associated with a wide range of clinical phenotypes hemolytic anemia and neurological impairment. Pseudogenes of this gene have been defined on chromosomes 19, 21 and the X chromosome. [provided by RefSeq, Jan 2014]
PGK1 Gene-Disease associations (from GenCC):
  • glycogen storage disease due to phosphoglycerate kinase 1 deficiency
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.36939877).
BP6
Variant X-78125810-G-A is Benign according to our data. Variant chrX-78125810-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 493535.
BS2
High Hemizygotes in GnomAdExome4 at 36 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000291.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PGK1
NM_000291.4
MANE Select
c.1234G>Ap.Asp412Asn
missense
Exon 11 of 11NP_000282.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PGK1
ENST00000373316.5
TSL:1 MANE Select
c.1234G>Ap.Asp412Asn
missense
Exon 11 of 11ENSP00000362413.4
PGK1
ENST00000644362.1
c.1150G>Ap.Asp384Asn
missense
Exon 11 of 11ENSP00000496140.1
PGK1
ENST00000476531.1
TSL:2
n.503G>A
non_coding_transcript_exon
Exon 2 of 2

Frequencies

GnomAD3 genomes
AF:
0.0000626
AC:
7
AN:
111908
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000437
AC:
8
AN:
183263
AF XY:
0.0000295
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000979
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000973
AC:
106
AN:
1089857
Hom.:
0
Cov.:
28
AF XY:
0.000101
AC XY:
36
AN XY:
355709
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26267
American (AMR)
AF:
0.00
AC:
0
AN:
35190
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19334
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30182
South Asian (SAS)
AF:
0.0000556
AC:
3
AN:
53943
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40522
Middle Eastern (MID)
AF:
0.00122
AC:
5
AN:
4093
European-Non Finnish (NFE)
AF:
0.000104
AC:
87
AN:
834481
Other (OTH)
AF:
0.000240
AC:
11
AN:
45845
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.451
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000626
AC:
7
AN:
111908
Hom.:
0
Cov.:
23
AF XY:
0.0000293
AC XY:
1
AN XY:
34072
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30745
American (AMR)
AF:
0.00
AC:
0
AN:
10556
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2642
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3584
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2695
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6081
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.000132
AC:
7
AN:
53174
Other (OTH)
AF:
0.00
AC:
0
AN:
1511
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000868
Hom.:
1
Bravo
AF:
0.0000642
ExAC
AF:
0.0000412
AC:
5
EpiCase
AF:
0.000327
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Glycogen storage disease due to phosphoglycerate kinase 1 deficiency Uncertain:2
Aug 29, 2023
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Jan 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PGK1: BS2

Oct 20, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.44
T
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.90
D
M_CAP
Benign
0.040
D
MetaRNN
Benign
0.37
T
MetaSVM
Uncertain
0.27
D
MutationAssessor
Benign
1.4
L
PhyloP100
7.2
PrimateAI
Uncertain
0.56
T
PROVEAN
Benign
-1.1
N
REVEL
Uncertain
0.34
Sift
Benign
0.18
T
Sift4G
Benign
0.087
T
Polyphen
0.0010
B
Vest4
0.11
MVP
0.84
MPC
0.11
ClinPred
0.21
T
GERP RS
5.2
Varity_R
0.67
gMVP
0.75
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs782165735; hg19: chrX-77381307; API